Cannabix Technologies announces Non-Brokered LIFE Private Placement

Executive Summary

• Cannabix Technologies Inc. announced a non‑brokered private placement of up to 4,255,319 units at C$0.47 per unit, targeting gross proceeds of $2 million CAD.
• Each unit consists of one common share and half of a non‑transferable warrant (exercise price C$0.60, 24‑month term) with an acceleration clause tied to the share price.
• Net proceeds will be used for manufacturing, inventory, product marketing, general & administrative expenses (including investor relations), and working capital.

Key Details

• Units Offered: Minimum 2,127,659 units; maximum 4,255,319 units.
• Price per Unit: C$0.47.
• Aggregate Gross Proceeds: $1 million CAD minimum; up to $2 million CAD maximum.
• Closing Date: On or about November 25, 2025, subject to approvals (including CSE).
• Unit Composition: 1 common share + ½ of one non‑transferable common share purchase warrant.
• Warrant Terms: Exercise price C$0.60 per share; exercisable for 24 months from issuance; includes acceleration right.
• Acceleration Clause: If the closing price ≥ C$0.75 for 10 consecutive trading days, Company may accelerate warrant expiry to 30 calendar days after notice, terminating holder rights without compensation.
• Insider Participation: Insiders may subscribe; deemed a related‑party transaction but expected to be exempt from MI 61‑101 valuation and minority approval thresholds (≤25% market cap).
• Finder’s Fees: Up to 8% cash of gross proceeds plus Finder’s Units up to 10% of units sold; Finder’s Units include one share + ½ warrant with same terms as above.
• Use of Proceeds: Funding manufacturing, inventory, product marketing, general & administrative expenses (including investor relations), and working capital.
• Investor Participation Right: One existing investor has a contractual right until May 15, 2026 for future equity financings; waiver received indicating they will not exercise it in this offering.

Notable Quotes

• “Rav Mlait”, CEO – signatory on behalf of the Board of Directors.